Press Releases

January 31, 2020

Cannara Biotech’s Farnham Facility Receives Cultivation Licence

Today announced the receipt of its cultivation licence from Health Canada for Phase 1 of its purpose-built Farnham Facility.

January 20, 2020

Cannara Biotech Reports Q1 2020 Financial Results

Today announced financial results for the three-month period ended November 30, 2019.

November 27, 2019

Cannara Biotech Reports Q4 and Year-End 2019 Financial Results

Today announced financial results for the three month period and year ended August 31, 2019.

October 10, 2019 

Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce

Announced it has secured a first mortgage against its Farnham Facility…

September 12, 2019

Cannara Biotech Submits Site Evidence Package to Health Canada
for its Quebec Facility

Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has submitted to Health Canada…

August 14, 2019

Cannara Announces Appointment of New Chief Operating Officer

Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried…

July 25, 2019

Cannara Biotech Inc. Reports Q3 2019 Results

Cannara Biotech (“Cannara” or the “Company”) (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products…

July 12, 2019

Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares

Cannara Biotech Inc. (the “Corporation” or “Cannara”) (CSE: LOVE, FRA: 8CB, OTCMKTS: LOVFF), an emerging vertically integrated cannabis company focused on cultivation, and cannabis-infused products, is pleased to announce that it has raised $2,160,000 by way of non- brokered…

June 14, 2019

President’s Message

It has been a highly productive first year for Cannara and I want to commend the entire team on delivering a number of impactful milestones in our first year within this exciting and continually evolving cannabis sector…

May 24, 2019

Cannara Biotech Appoints Dr. Sara May to its Board of Directors

Cannara Biotech (“Cannara” or the “Company”) (CSE: LOVE, FRA: 8CB, OTCMKTS: CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Dr. Sara May, PhD. to the…

May 15, 2019

Cannara Biotech Commences Trading on the OTCQB Market in the United States

Cannara Biotech (“Cannara” or the “Company”) (CSE: LOVE, FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried cannabis and cannabis-infused…

April 29, 2019

Cannara Biotech Reports Q2 2019 Results

Cannara Biotech (“Cannara” or the “Company”) (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried cannabis and cannabis-infused products to the Canadian and international markets, today…

March 12, 2019

Cannara Biotech Announces Expansion of Phase 1 Build-Out and Board of Directors Update

Cannara Biotech Inc. (“Cannara” or the “Company”) (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company in the making focused on cultivation and cannabis- infused products, today announced an expansion of the Phase 1 build-out of Cannara’s facility from 130,000 to 170,000 square feet. As a result, the license application at Cannara’s Farnham, in process with…

February 11, 2019

Cannara Biotech Shares to Begin Trading on the Frankfurt Exchange

Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company focused on cultivation and cannabis- infused products, today announced its…

February 07, 2019

Cannara Biotech Enters Cannabinoid-Infused Beverage Product Category Partners with a Leading Quebec Microbrewery

Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE), a Montreal-based company that is building a vertically integrated cannabis company focused on cultivation and cannabis…

January 29, 2019

Cannara Biotech Reports First Quarter Results

Cannara Biotech Inc. (“Cannara” or the “Company”) (CSE: LOVE), is building a vertically integrated Cannabis company focused on cannabis derivative products, today announced its financial results for the three-month period ended November 30, 2018…

January 24, 2019

Cannara Biotech to Enter the U.S. Hemp-CBD Market. Launching an Online E-Commerce Platform – ShopCBD.com

Cannara Biotech Inc. (“Cannara” or the “Company”) (CSE: LOVE), is building a vertically integrated Cannabis company focused on cannabis-infused products, today announced it is entering the U.S. Hemp-CBD market, through a subsidiary, with an online e-commerce platform called shopCBD.com…

January 11, 2019

Cannara Biotech to Commence Trading on CSE Monday January 14 Under Ticker Symbol “LOVE”

Cannara Biotech Inc. (“Cannara” or the “Company”), a vertically integrated Cannabis company focused on cannabis derivative products, is pleased to announce that its common shares will begin trading on Monday, January 14, 2019 on the Canadian Securities Exchange (CSE) under the symbol “LOVE.”